The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Prodrug strategies to overcome poor water solubility
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rates
Schywalsky, M., Ihmsen, H., Tzabazis, A., Fechner, J., Burak, E. S., Vornov, J. J., & Schwilden, H. (2005) · European Journal of Anaesthesiology · doi:10.1017/s0265021503000322 · Cited by 41
RetractedLipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Miyashiro, J. M., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960803q · Cited by 1,965
Effective drug delivery by PEGylated drug conjugates
Greenwald, R. B., Choe, Y. H., McGuire, J., & Conover, C. D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00180-1 · Cited by 869
Hörter, D., & Dressman, J. B. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00130-7 · Cited by 819
Bernard, Testa, M., Meyer, U., & Testa, B. (1964) · Academic Press eBooks · Cited by 609
Martinez, M. N., & Amidon, G. L. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00970002042006005 · Cited by 536
Prasit, P., Wang, Z., Brideau, C., Chan, C.-C., Charleson, S., Cromlish, W., Ethier, D., Evans, J. F., Ford-Hutchinson, A. W., Gauthier, J. Y., et al. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00288-7 · Cited by 429
Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract
Hörter, D., & Dressman, J. B. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00487-5 · Cited by 393
Lessons Learned from Marketed and Investigational Prodrugs
Ettmayer, P., Amidon, G. L., Clement, B., & Testa, B. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0303812 · Cited by 384
Slatter, J. G., Schaaf, L. J., Sams, J. P., Feenstra, K. L., Johnson, M. G., Bombardt, P. A., Cathcart, K. S., Verburg, M. T., Pearson, L. K., Compton, L. D., et al. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15060-x · Cited by 302
P-Glycoprotein Recognition of Substrates and Circumvention through Rational Drug Design
Raub, T. J. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0500871 · Cited by 221
Talley, J. J., Bertenshaw, S. R., Brown, D. L., Carter, J. S., Graneto, M. J., Kellogg, M. S., Koboldt, C. M., Yuan, J., Zhang, Y. Y., & Seibert, K. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000069h · Cited by 213
Nicolaides, E., Symillides, M., Dressman, J. B., & Reppas, C. (2001) · Pharmaceutical Research · doi:10.1023/a:1011071401306 · Cited by 208
Progress in understanding the structure–activity relationships of P-glycoprotein
Stouch, T. R., & Gudmundsson, O. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00006-6 · Cited by 181
Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum
Moreno, M. P. D. L. C., Oth, M., Deferme, S., Lammert, F., Tack, J., Dressman, J., & Augustijns, P. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.8.0009 · Cited by 180
Prodrugs : challenges and rewards
Stella, V. J. (2007) · Cited by 153
Self-citationSynthesis and in Vivo Antitumor Activity of Poly( l -glutamic acid) Conjugates of 20(S)-Camptothecin
Bhatt, R., de Vries, P. W., Tulinsky, J., Bellamy, G., Baker, B., Singer, J. W., & Klein, P. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020022r · Cited by 152
Poly(ethylene glycol) Conjugated Drugs and Prodrugs: A Comprehensive Review
Greenwald, R. B., Conover, C. D., & Choe, Y. H. (2000) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v17.i2.20 · Cited by 133
Pharmaceutical profiling in drug discovery for lead selection
Borchardt, R. T. (2004) · Cited by 130
Wire, M. B., Shelton, M. J., & Studenberg, S. D. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645020-00002 · Cited by 127
Fischer, J. H., Patel, T. V., & Fischer, P. A. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342010-00002 · Cited by 125
Ruggeri, B., Singh, J., Gingrich, D. E., Angeles, T. S., Albom, M. S., Yang, S., Chang, H., Robinson, C., Hunter, K., Dobrzański, P., et al. (2003) · PubMed · Cited by 125
Prodrug research: futile or fertile?
Testa, B. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.005 · Cited by 124
Metabolism and action of fludarabine phosphate.
Plunkett, W. K., Huang, P., & Gandhi, V. V. (1990) · PubMed · Cited by 117
Hydrolysis in drug and prodrug metabolism : chemistry, biochemistry, and enzymology
Testa, B., & Mayer, J. M. (2003) · Medical Entomology and Zoology · Cited by 113
Perry, C. M., & McTavish, D. (1995) · Drugs & Aging · doi:10.2165/00002512-199507010-00006 · Cited by 88
Stella, V. J. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.3.277 · Cited by 87
Self-citationHayashi, Y., Skwarczyński, M., Hamada, Y., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034112n · Cited by 85
Absorption Rate Limit Considerations for Oral Phosphate Prodrugs
Heimbach, T., Oh, D.-M., Li, L. Y., Forsberg, M., Savolainen, J., Leppänen, J., Matsunaga, Y., Flynn, G. L., & Fleisher, D. (2003) · Pharmaceutical Research · doi:10.1023/a:1023827017224 · Cited by 79
Leu, Y.-L., Roffler, S. R., & Chern, J. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990124q · Cited by 78
Sohma, Y., Hayashi, Y., Skwarczyński, M., Hamada, Y., Sasaki, M., Kimura, T., & Kiso, Y. (2004) · Biopolymers · doi:10.1002/bip.20136 · Cited by 74
Laubach, G. D., Pan, S., & RUDEL, H. W. (1955) · Science · doi:10.1126/science.122.3158.78-a · Cited by 66
A case for prodrugs: Fosphenytoin
Stella, V. J. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00112-k · Cited by 62
Self-citationKinetics of methylprednisolone and its hemisuccinate ester
Derendorf, H., Möllmann, H., Rohdewald, P. J., et al. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.79 · Cited by 59
Krise, J. P., Zygmunt, J., Georg, G. I., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980539w · Cited by 50
Baker, W. R., Cai, S., Dimitroff, M., Fang, L., Huh, K., Ryckman, D., Shang, X., Shawar, R. M., & Therrien, J. H. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0497895 · Cited by 46
Bentley, A., Butters, M., Green, S. P., Learmonth, W. J., MacRae, J., Morland, M. C., O'Conno, G., & Skuse, J. (2001) · Organic Process Research & Development · doi:10.1021/op010064+ · Cited by 44
Stella, V. J., Martodihardjo, S., Terada, K., & Rao, V. M. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980008v · Cited by 41
Self-citationProdrugs of HIV Protease Inhibitors
Vierling, P., & Greiner, J. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454441 · Cited by 32
Yagi, S., Ono, J., Yoshimoto, J., Sugita, K.-I., Hattori, N., Fujioka, T., Fujiwara, T., Sugimoto, H., Hirano, K., & Hashimoto, N. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983715982 · Cited by 29
Stella, V. J., Rao, V. M., & Martodihardjo, S. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980489i · Cited by 28
Self-citationDose-dependent pharmacokinetics of rapamycin-28-N,N-dimethylglycinate in the mouse
Supko, J. G., & Malspeis, L. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685908 · Cited by 27
Hanson, B. A., Schowen, R. L., & Stella, V. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1024410322870 · Cited by 26
Self-citationComparative Pharmacokinetics of Methylprednisolone Phosphate and Hemisuccinate in High Doses
Möllmann, H., Rohdewald, P. J., Barth, J., et al. (1988) · Pharmaceutical Research · doi:10.1023/a:1015921408870 · Cited by 25
Hegde, S. G., & Schmidt, M. A. (2006) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(06)41030-7 · Cited by 25
Sobue, S., Tan, K., & Haug‐Pihale, G. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02234.x · Cited by 23
Sobue, S., Tan, K., Layton, G. R., Leclerc, V., & Weil, A. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02073.x · Cited by 21
Pharmacokinetics of dapsone and amino acid prodrugs of dapsone.
Pochopin, N. L., Charman, W. N., & Stella, V. J. (1994) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07567-1 · Cited by 20
Self-citationSolubility, Solubilization and Dissolution in Drug Delivery During Lead Optimization
Hageman, M. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-44961-6_5 · Cited by 12
Bioavailability comparison between albendazole and albendazole sulphoxide in rats and man.
Domínguez, L., Fagiolino, P. L., Gordon, S., et al. (1995) · PubMed · Cited by 10
Cited by
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,630
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., & Onoue, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.032 · Cited by 1,181
Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?
Brouwers, J., Brewster, M. E., & Augustijns, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21650 · Cited by 947
The expanding role of prodrugs in contemporary drug design and development
Rautio, J., Meanwell, N. A., Di, L., & Hageman, M. J. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.46 · Cited by 767
Metadata
- Authors
- Stella, V. J., & Nti-Addae, K. W.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 59
- Issue
- 7
- Pages
- 677-694
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1979657535
- Cited by
- 554
- References
- 53
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.